Home › Funds › Anfield Capital Management, LLC › ROIV

Anfield Capital Management, LLC position in ROIV

ROIVANT SCIENCES LTD · Health Care

Anfield Capital Management, LLC reported holding 119,451 shares of ROIV (ROIVANT SCIENCES LTD) in its Q1 2026 13F filing — a position valued at US$3.3M, representing 0.91% of its reported portfolio and ranking #24 among its reported holdings. Anfield Capital Management, LLC has disclosed ROIV holdings in 3 of the last 3 reported quarters, going back to Q3 2025.

Latest position (Q1 2026)119.45K sh
Reported value held$3.31M
Portfolio Weight0.91%
First reportedQ3 2025
Last changeHold
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Anfield Capital Management, LLC's ROIV position evolved

Anfield Capital Management, LLC first disclosed a stake in ROIV in Q3 2025 at 155,644 shares (US$2.4M). The position peaked in Q1 2026 at 119,451 shares, worth US$3.3M. Across 3 filings, Anfield Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q1 2026) shows 119,451 shares valued at US$3.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 155.64K $2.35M New
Q4 2025 118.95K $2.58M Reduce
Q1 2026 119.45K $3.31M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 64 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Anfield Capital Management, LLC held ROIV?

Anfield Capital Management, LLC has disclosed ROIV holdings in 3 of the last 3 reported quarters, going back to Q3 2025.

What is Anfield Capital Management, LLC's current position in ROIV?

As of Q1 2026, Anfield Capital Management, LLC holds 119.45K shares of ROIV (ROIVANT SCIENCES LTD), valued at $3.31M, representing 0.91% of its reported portfolio and ranking #24.

Has Anfield Capital Management, LLC been buying or selling ROIV?

In the latest 13F filing (Q1 2026), Anfield Capital Management, LLC held unchanged its position in ROIV. The position peaked in Q1 2026 at 119.45K shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.